World leader in analytical laboratory instrumentations selects Global 2.0 to manage its medical products approvals and submissions worldwide.
Framingham, MA, April 25, 2006 – clinivation, Inc. announced today that Waters Corporation (NYSE: WAT) has selected clinivation Global™ 2.0 software.
“Waters Corporation’s products and services are synonymous with quality and performance in analytical labs around the world,” said Joseph Kozikowski, M.D., clinivation’s Chief Executive Officer.
“We are delighted that Waters Corporation’s management has selected clinivation Global 2.0 to help them build and track their medical product approvals and submissions worldwide,” he continued.
Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.
About Waters Corporation
Waters Corporation holds worldwide leading positions in three complementary analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis. These market segments account for $4.5 – $5.0 billion of the overall $20+ billion analytical instrumentation market.
For more information, visit www.waters.com
